Acutus Medical, Inc. (AFIB) Comparison with companies in other sectors?

Acutus Medical, Inc. has a share price of 29.91M. You can analyze Acutus Medical, Inc. (AFIB) competitors across different market sectors through stock heatmaps.

What are AFIB's NET and operating margins?

Acutus Medical, Inc. (AFIB) operating margin is around -0.00, and net profit margin is approximately -0.47 as of the latest reports.

In what way does AFIB's earnings per share (EPS) trend reflect its financial momentum?

Acutus Medical, Inc. (AFIB) EPS is -0.15 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Acutus Medical, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Acutus Medical, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Acutus Medical, Inc. like P/E which is -0.00, P/B which is -0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Acutus Medical, Inc.

AFIB•NASDAQ

Healthcare

Medical - Devices

$0.001

$0.00(150.00%)

Fundamental Analysis of Acutus Medical, Inc. (AFIB)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.15

P/E Ratio

ROE

1.24%

Net Margin

-0.47%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.98K

Shares OutstandingTotal number of shares issued

$29.91M

Book Value/ShareNet worth per share

$-0.39

Revenue/ShareAnnual revenue per share

$0.68

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.15

Net MarginNet income as percentage of revenue

-47.36%

Operating MarginOperating income as percentage of revenue

-0.28%

ROEReturn on shareholders' equity

124.33%

ROAReturn on total assets

-33.33%

ROCEReturn on capital employed

-0.35%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.07

Cash/ShareCash and equivalents per share

$0.47

FCF YieldFree cash flow as percentage of market cap

-531126.71%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for AFIBFinancial Ratios Analysis details for AFIB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AFIBSector Benchmarking details for AFIB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Acutus Medical, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Acutus Medical, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Acutus Medical, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Acutus Medical, Inc.

For Acutus Medical, Inc., essential financial indicators include EPS -0.15, PE -, and ROE 1.24. These key ratios reveal insights into Acutus Medical, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Acutus Medical, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Acutus Medical, Inc.

Metrics like Net Margin -47.36% and ROA -33.33% shed light on how well Acutus Medical, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Acutus Medical, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Acutus Medical, Inc.

Using ratios such as P/B Ratio -0.00 and PEG Ratio 0.00, investors can assess whether Acutus Medical, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Acutus Medical, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Acutus Medical, Inc.

Financial health indicators, such as Debt/Equity Ratio -3.09 and Cash Flow $-1.07, provide a snapshot of Acutus Medical, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Acutus Medical, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Acutus Medical, Inc.

Investing in Acutus Medical, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Acutus Medical, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;